Therapeutic Advances in Neurological Disorders

Top Research Topics at Therapeutic Advances in Neurological Disorders?

Therapeutic Advances in Neurological Disorders investigates areas of study like Multiple sclerosis, Internal medicine, Disease, Immunology and In patient. The research on Multiple sclerosis tackled can also make contributions to studies in the areas of Clinical trial, Pathology and Intensive care medicine. The in-depth study on Clinical trial also explores topics in the intersecting field of Pharmacology.

Tolerability is a primary topic of Pharmacology research in Therapeutic Advances in Neurological Disorders. Discussions in it are anchored in the subject of Intensive care medicine and the similar topic of Alternative medicine. While Internal medicine is the focus of it, it also provided insights into the studies of Gastroenterology, Surgery, Oncology and Cardiology.

Some problems in Disease that were presented in Therapeutic Advances in Neurological Disorders overlapped with concepts under Psychiatry, Magnetic resonance imaging and Bioinformatics. The works on Psychiatry deal in particular with Epilepsy. Therapeutic Advances in Neurological Disorders focuses on different Immunology studies like Antibody, Immune system, Myasthenia gravis, Rituximab and Monoclonal antibody.

• Multiple sclerosis (36.13%)
• Internal medicine (25.16%)
• Disease (17.26%)

What are the most cited papers published in the journal?

• Current and future treatments for Alzheimer's disease. (303 citations)
• Sex and gender issues in multiple sclerosis (223 citations)
• The cognitive impact of antiepileptic drugs (198 citations)

Research areas of the most cited articles at Therapeutic Advances in Neurological Disorders:

The most cited publications primarily tackle Multiple sclerosis, Disease, Immunology, Internal medicine and Psychiatry. Issues in Multiple sclerosis were discussed in the journal papers, taking into consideration concepts from other disciplines like Clinical trial, Central nervous system, Intensive care medicine, Alternative medicine and Physical therapy. The published papers explore topics in Disease which can be helpful for research in disciplines like Pathological and Bioinformatics.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Surgery

The previous edition focused in particular on these issues:

Therapeutic Advances in Neurological Disorders primarily focuses on research topics in Multiple sclerosis, Internal medicine, In patient, Disease and Stroke. Topics in Multiple sclerosis were tackled in line with various other fields like Cohort and Vaccination. The Internal medicine works featured in the journal incorporate elements from Gastroenterology, Oncology and Cardiology.

Attendees participated in lively discussions that mix various fields of study, including In patient and Immunology and Radiology. The Disease study featured in the journal draws connections with the study of Magnetic resonance imaging. The research on Stroke featured in the journal combines topics in other fields like Intervention (counseling), Clinical trial and Intensive care medicine.

The most cited articles from the last journal are:

• Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies (66 citations)
• Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection (5 citations)
• Inflammation in multiple sclerosis (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Therapeutic Advances in Neurological Disorders (based on the number of publications) are:

• Ralf Gold (39 papers) published 7 papers at the last edition, 4 more than at the previous edition,
• Georgios Tsivgoulis (17 papers) published 5 papers at the last edition, 3 more than at the previous edition,
• Olaf Stüve (16 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Kerstin Hellwig (15 papers) published 3 papers at the last edition, 2 less than at the previous edition,
• Andrew T. Chan (14 papers) published 5 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutic Advances in Neurological Disorders (based on the number of publications) are:

• Ruhr University Bochum (58 papers) published 10 papers at the last edition, 1 more than at the previous edition,
• National and Kapodistrian University of Athens (32 papers) published 8 papers at the last edition, 4 more than at the previous edition,
• University of Düsseldorf (25 papers) published 7 papers at the last edition,
• University of Texas Southwestern Medical Center (22 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• University of Münster (19 papers) published 6 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.14% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 54.02% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.20% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.79% of all publications and 22.99% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Pathways in Neurological Disorders Research

In addition to contributing to ground-breaking research in Neurological Disorders, a deep understanding of these topics also opens pathways to various healthcare careers. One such career is a Nurse Practitioner specializing in neurological disorders. This unique medical profession requires a detailed understanding of neurology and the ability to apply it in patient care. In some instances, research roles in neurological disorders intertwine with active roles in patient care.

For those interested in combining research and patient care, the requirements to become a Nurse Practitioner specialized in neurological disorders may vary from one region to another. In the state of South Dakota, for example, specific education, licensing and certification requirements exist. This pathway provides an opportunity to be at the forefront of neurological research while directly impacting patient lives. Learn more specifics on how to be a Nurse Practitioner in South Dakota.

Similarly, there are many other careers in the research and healthcare field related to neurological disorders, providing a broad spectrum of opportunities for those interested in this vital scientific field.